Esophageal Cancer Clinical Trials in New Taipei City
2 recruitingNew Taipei City, Taiwan
Showing 1–2 of 2 trials
Recruiting
Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
Triple-Negative Breast CancerPancreatic CancerNon-small Cell Lung Cancer+4 more
AbbVie512 enrolled35 locationsNCT05005403
Recruiting
Personalized Nutrition Counseling and Nutritional Status of Esophageal Cancer and HNSCC Patients Undergoing CCRT
Esophageal CancerPersonalized Nutrition
Chang Gung Memorial Hospital90 enrolled1 locationNCT06829095